Is COVID Vaccine Associated with Development of De Novo Donor Specific Antibodies in Lung Transplant Recipients?

被引：0
|
作者：
Nandavaram, S. [1 ]
Benninger, L. [2 ]
Scheuble, V. [3 ]
Chandrashekaran, S. [4 ]
机构：
[1] Univ Kentucky, Lexington, KY USA
[2] Cleveland Clin, Cleveland, OH USA
[3] Univ Florida, Gainesville, FL USA
[4] Emory Hlth Care, Atlanta, GA USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2022年 / 41卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
354
引用
收藏
页码：S158 / S159
页数：2
相关论文
共 50 条
  • [1] PERSISTENT DE NOVO DONOR-SPECIFIC ANTIBODIES ARE ASSOCIATED WITH DECREASED SURVIVAL IN LUNG TRANSPLANT RECIPIENTS
    Kauke, Teresa
    Schmitzer, Magdalena
    Kneidinger, Nikolaus
    Neurohr, Claus
    Schramm, Rene
    Von Dossow, Vera
    Winter, Hauke
    [J]. TRANSPLANT INTERNATIONAL, 2017, 30 : 33 - 33
  • [2] What Stimulates the Development of De Novo Donor Specific Antibodies in Cardiac Transplant Recipients?
    Gupta, Richa
    Schlendorf, Kelly
    Fossey, Sallyanne
    Brinkley, Douglas M.
    Menachem, Jonathan N.
    Punnoose, Lynn R.
    Sacks, Suzanne Brown
    Ooi, Henry
    Wigger, Mark
    Zalawadiya, Sandip K.
    Lindenfeld, JoAnn
    [J]. JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S170 - S170
  • [3] Incidence of De Novo Donor Specific Antibodies in Kidney Transplant Recipients
    Staino, C.
    Pilch, N.
    Moussa, O.
    Boyle, K.
    Casale, J.
    Covert, K.
    Fleming, J.
    Taber, D.
    Meadows, H.
    Mardis, C.
    Chavin, K.
    Nadig, S.
    McGillicuddy, J.
    Bratton, C.
    Srinivas, T.
    Baliga, P.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [4] Carfilzomib versus Rituximab for Treatment of De Novo Donor Specific Antibodies in Lung Transplant Recipients
    Razia, D.
    Hu, C.
    Cherrier, L.
    Nasar, A.
    Walia, R.
    Tokman, S.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S112 - S113
  • [5] Carfilzomib versus rituximab for treatment of de novo donor-specific antibodies in lung transplant recipients
    Razia, Deepika
    Hu, Chengcheng
    Cherrier, Lauren
    Nasar, Aasya
    Walia, Rajat
    Tokman, Sofya
    [J]. TRANSPLANT IMMUNOLOGY, 2022, 75
  • [6] Outcomes of De Novo Donor Specific Antibodies in Pancreas Transplant Recipients.
    Parajuli, S.
    Alagusundaramoorthy, S.
    Aziz, F.
    Garg, N.
    Redfield, R.
    Sollinger, H.
    Kaufman, D.
    Djamali, A.
    Odorico, J.
    Mandelbrot, D.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 432 - 432
  • [7] Outcomes of Pancreas Transplant Recipients With De Novo Donor-specific Antibodies
    Parajuli, Sandesh
    Alagusundaramoorthy, Sayee
    Aziz, Fahad
    Garg, Neetika
    Redfield, Robert R.
    Sollinger, Hans
    Kaufman, Dixon
    Djamali, Arjang
    Odorico, Jon
    Mandelbrot, Didier
    [J]. TRANSPLANTATION, 2019, 103 (02) : 435 - 440
  • [8] Outcomes in Kidney Transplant Recipients That Develop De Novo Donor Specific Antibodies
    DeVos, J. M.
    Patel, S. J.
    Land, G.
    Knight, R. J.
    Achkar, K.
    Dilioglou, S.
    Dawson, K. L.
    Abdellatif, A.
    Gaber, A. O.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 294 - 294
  • [9] The Clinical Spectrum Of De Novo Donor Specific Antibodies In Paediatric Renal Transplant Recipients
    Kim, Jon Jin
    Balasubramanian, Ramnath
    Michaelides, George
    Wittenhagen, Per
    Sebire, Neil
    Shaw, Olivia
    Vaughan, Robert
    Marks, Stephen
    [J]. PEDIATRIC NEPHROLOGY, 2014, 29 (09) : 1682 - 1682
  • [10] De Novo Donor Specific Antibodies in Pediatric Renal Transplant Recipients: Response to Therapy
    Tsai, E.
    Tzeng, J.
    Gjertson, D.
    Ettenger, R.
    Reed, E.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 443 - 443
12345